FDA.reportPublic FDA data

Application 210322

Type
ANDA
Sponsor
CIPLA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ISOPROTERENOL HYDROCHLORIDEISOPROTERENOL HYDROCHLORIDEINJECTABLE;INJECTION0.2MG/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
69097-521ISOPROTERENOLisoproterenol hydrochlorideCipla USA Inc.ANDACurrent
69097-521ISOPROTERENOLisoproterenol hydrochlorideCipla USA Inc.ANDACurrent
69097-521ISOPROTERENOLisoproterenol hydrochlorideCipla USA Inc.ANDACurrent
69097-521ISOPROTERENOLisoproterenol hydrochlorideCipla USA Inc.ANDACurrent
69097-522ISOPROTERENOLisoproterenol hydrochlorideCipla USA Inc.ANDACurrent
69097-522ISOPROTERENOLisoproterenol hydrochlorideCipla USA Inc.ANDACurrent
69097-522ISOPROTERENOLisoproterenol hydrochlorideCipla USA Inc.ANDACurrent
69097-522ISOPROTERENOLisoproterenol hydrochlorideCipla USA Inc.ANDACurrent